MITCHELL DEAN J has filed 19 insider transactions across 3 companies since March 2023.
Most recent transaction: a option exercise of 8566 shares of Praxis Precision Medicines, Inc. ($PRAX) on September 24, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 24, 2025 | Praxis Precision Medicines, Inc. | $PRAX | MITCHELL DEAN J | Director | M | Stock Option (Right to Buy) | 8566 | $0.00 | 0.0000 | 20,163,250 | 100.00% | 0.04% |
| Sept. 24, 2025 | Praxis Precision Medicines, Inc. | $PRAX | MITCHELL DEAN J | Director | M | Common Stock | 8566 | $44.25 | 15,498.0000 | 20,163,250 | 123.57% | 0.04% |
| Sept. 24, 2025 | Praxis Precision Medicines, Inc. | $PRAX | MITCHELL DEAN J | Director | M | Stock Option (Right to Buy) | 1753 | $0.00 | 8,767.0000 | 20,163,250 | 16.66% | 0.01% |
| Sept. 24, 2025 | Praxis Precision Medicines, Inc. | $PRAX | MITCHELL DEAN J | Director | M | Common Stock | 1932 | $14.36 | 6,932.0000 | 20,163,250 | 38.64% | 0.01% |
| Sept. 24, 2025 | Praxis Precision Medicines, Inc. | $PRAX | MITCHELL DEAN J | Director | M | Stock Option (Right to Buy) | 1932 | $0.00 | 0.0000 | 20,163,250 | 100.00% | 0.01% |
| Sept. 24, 2025 | Praxis Precision Medicines, Inc. | $PRAX | MITCHELL DEAN J | Director | M | Common Stock | 1753 | $44.04 | 17,251.0000 | 20,163,250 | 11.31% | 0.01% |
| June 26, 2025 | Praxis Precision Medicines, Inc. | $PRAX | MITCHELL DEAN J | Director | A | Stock Option (Right to Buy) | 10520 | $0.00 | 10,520.0000 | 20,163,250 | 9999.99% | 0.05% |
| May 19, 2025 | Theravance Biopharma, Inc. | $TBPH | MITCHELL DEAN J | Not found | A | Ordinary Shares | 10649 | $0.00 | 91,204.0000 | 49,706,000 | 13.22% | 0.02% |
| May 19, 2025 | Theravance Biopharma, Inc. | $TBPH | MITCHELL DEAN J | Not found | A | Share Option (Right to Buy) | 24258 | $0.00 | 24,258.0000 | 49,706,000 | 9999.99% | 0.05% |
| June 5, 2024 | Praxis Precision Medicines, Inc. | $PRAX | MITCHELL DEAN J | Director | A | Stock Option (Right to Buy) | 8566 | $0.00 | 8,566.0000 | 0 | 9999.99% | 0.00% |
| May 8, 2024 | Theravance Biopharma, Inc. | $TBPH | MITCHELL DEAN J | Not found | A | Share Option (Right to Buy) | 23576 | $0.00 | 23,576.0000 | 48,283,000 | 9999.99% | 0.05% |
| May 8, 2024 | Theravance Biopharma, Inc. | $TBPH | MITCHELL DEAN J | Not found | A | Ordinary Shares | 10537 | $0.00 | 80,555.0000 | 48,283,000 | 15.05% | 0.02% |
| March 14, 2024 | PRECIGEN, INC. | $PGEN | MITCHELL DEAN J | Director | A | Option to Purchase Common Stock (Right to Buy) | 101626 | $0.00 | 101,626.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | PRECIGEN, INC. | $PGEN | MITCHELL DEAN J | Director | A | Restricted Stock Units | 87412 | $0.00 | 87,412.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | PRECIGEN, INC. | $PGEN | MITCHELL DEAN J | Director | A | Common Stock | 39510 | $1.43 | 503,183.0000 | 0 | 8.52% | 0.00% |
| March 9, 2024 | PRECIGEN, INC. | $PGEN | MITCHELL DEAN J | Director | M | Restricted Stock Units | 106837 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 9, 2024 | PRECIGEN, INC. | $PGEN | MITCHELL DEAN J | Director | M | Common Stock | 106837 | $0.00 | 463,673.0000 | 0 | 29.94% | 0.00% |
| June 12, 2023 | Praxis Precision Medicines, Inc. | $PRAX | MITCHELL DEAN J | Director | A | Stock Option (Right to Buy) | 28981 | $0.00 | 28,981.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Praxis Precision Medicines, Inc. | $PRAX | MITCHELL DEAN J | Director | P | Common Stock | 50000 | $0.84 | 75,000.0000 | 0 | 200.00% | 0.00% |